Prospects of siponimod in secondary progressive multiple sclerosis

被引：2
|
作者：
McGinley, Marisa [1 ]
Fox, Robert J. [1 ]
机构：
[1] Cleveland Clin, 9500 Euclid Ave,U-10, Cleveland, OH 44120 USA
来源：
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS | 2018年 / 11卷
关键词：
D O I：
10.1177/1756286418788013
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis
    Martin Vališ
    Anat Achiron
    Hans Peter Hartung
    Jan Mareš
    Veronika Tichá
    Pavel Štourač
    Simona Halusková
    Francesco Angelucci
    Zbyšek Pavelek
    [J]. Drugs in R&D, 2023, 23 : 331 - 338
  • [32] Investigating the relationship between Siponimod efficacy in secondary progressive multiple sclerosis and pathogenic Th cell populations
    Raveney, B.
    Katsumoto, A.
    Kurosawa, R.
    Lin, Y.
    Takahashi, Y.
    Okamoto, T.
    Oki, S.
    Sato, W.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 774 - 775
  • [33] STICK OR TWIST? COST-EFFECTIVENESS OF SIPONIMOD IN THE TREATMENT OF ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN THE UK
    Montgomery, S.
    Woodhouse, F.
    Vudumula, U.
    Gudala, K.
    Kroes, M.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S55 - S56
  • [34] Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series
    Abbadessa, Gianmarco
    Maida, Elisabetta
    Miele, Giuseppina
    Bile, Floriana
    Lavorgna, Luigi
    Bonavita, Simona
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [35] Siponimod Improves Cognitive Processing Speed in Patients with Secondary Progressive Multiple Sclerosis: EXPAND Subgroup Analyses
    Benedict, R.
    Tomic, D.
    Fox, R.
    Cree, B.
    Vermersch, P.
    Giovannoni, G.
    Bar-Or, A.
    Gold, R.
    Ritter, Sh.
    Karlsson, G.
    Wolf, C.
    Kappos, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (08) : NP20 - NP21
  • [36] Siponimod improves cognitive processing speed in patients with secondary progressive multiple sclerosis: EXPAND subgroup analyses
    Benedict, R.
    Fox, R.
    Tomic, D.
    Cree, B.
    Vermersch, P.
    Giovannoni, G.
    Bar-or, A.
    Gold, R.
    Ritter, S.
    Karlsson, G.
    Wolf, C.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 868 - 868
  • [37] Dual mode of action of siponimod in secondary progressive multiple sclerosis: a hypothesis based on the relevance of pharmacological properties
    Bigaud, M.
    Dahlke, F.
    Hach, T.
    Piani-Meier, D.
    Gold, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 273 - 273
  • [38] Siponimod for multiple sclerosis
    Cao, Liujiao
    Li, Meixuan
    Yao, Liang
    Yan, Peijing
    Wang, Xiaoqin
    Yang, Zhen
    Lao, Yongfeng
    Li, Huijuan
    Yang, Kehu
    Li, Ka
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (11):
  • [39] Siponimod (BAF312) for the Treatment of Secondary Progressive Multiple Sclerosis: Design of the Phase 3 EXPAND Trial
    Kappos, Ludwig
    Bar-Or, Amit
    Cree, Bruce
    Fox, Robert
    Giovannoni, Gavin
    Gold, Ralf
    Vermersch, Patrick
    Lam, Elaine
    Pohlmann, Harold
    Zhang-Auberson, Lixin
    Dandekar, Atul
    Wallstroem, Erik
    [J]. NEUROLOGY, 2013, 80
  • [40] Short- and long-term effects of siponimod on autonomic nervous system in secondary progressive multiple sclerosis
    Habek, Mario
    Junakovic, Anamari
    Karic, Antea
    Crnosija, Luka
    Barun, Barbara
    Gabelic, Tereza
    Adamec, Ivan
    Skoric, Magdalena Krbot
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 64
12345